A registry for gastric cancer patients and their families
The Gastric Cancer Foundation: A Gastric Cancer Registry
Stanford University · NCT01514045
This study is collecting information from people with gastric cancer, their families, and those with a specific gene mutation to see how different factors affect treatment and survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Stanford University (other) |
| Locations | 1 site (Stanford, California) |
| Trial ID | NCT01514045 on ClinicalTrials.gov |
What this trial studies
The Gastric Cancer Registry collects data from patients diagnosed with gastric cancer, those with a family history of the disease, and individuals with a known CDH1 gene mutation. Participants complete an online questionnaire and may provide blood, saliva, or tissue samples to enhance the understanding of gastric cancer's causes and outcomes. The registry aims to analyze both environmental and genetic factors that influence treatment responses and survival rates in gastric cancer patients.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a diagnosis of gastric cancer, a family history of the disease, or a known CDH1 gene mutation.
Not a fit: Patients under 18 years of age or those without a history of gastric cancer or related genetic mutations may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and management of gastric cancer, potentially enhancing patient outcomes.
How similar studies have performed: Other studies have shown success in utilizing registries to gather valuable data on cancer outcomes, making this approach both relevant and promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients are eligible if they have a histologically proven gastric tumor including gastroesophageal tumors; OR they have a family history of gastric cancer in a first or second degree relative; OR persons with a known germline mutation in their CDH1 (E-Cadherin) gene. 2. 18 years of age or older 3. Adequate English proficiency to complete online consent and questionnaire. Spanish-language proficiency as an alternative to English-language proficiency. Exclusion Criteria: 1. Under 18 years of age 2. No history of gastric cancer or gastric cancer in a family member or a known germline mutation in their CDH1 gene.
Where this trial is running
Stanford, California
- Stanford University, School of Medicine — Stanford, California, United States (RECRUITING)
Study contacts
- Principal investigator: Hanlee P Ji, MD — Stanford University
- Study coordinator: Alison Almeda
- Email: GCRegistry@stanford.edu
- Phone: 650-497-3619
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gastric Cancer, Quality of Life